These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 31652595)

  • 1. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity.
    Tanase DM; Gosav EM; Radu S; Costea CF; Ciocoiu M; Carauleanu A; Lacatusu CM; Maranduca MA; Floria M; Rezus C
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the kidney injury molecule-1 predict cisplatin-induced kidney injury in early stage?
    Tekce BK; Uyeturk U; Tekce H; Uyeturk U; Aktas G; Akkaya A
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):88-94. PubMed ID: 24670880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation.
    Yang C; Guo Y; Huang TS; Zhao J; Huang XJ; Tang HX; An N; Pan Q; Xu YZ; Liu HF
    Biomed Pharmacother; 2018 Nov; 107():1354-1362. PubMed ID: 30257350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times.
    Oh SM; Park G; Lee SH; Seo CS; Shin HK; Oh DS
    BMC Complement Altern Med; 2017 Dec; 17(1):544. PubMed ID: 29258482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cisplatin-induced injury in human kidney organoids.
    Digby JLM; Vanichapol T; Przepiorski A; Davidson AJ; Sander V
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F971-F978. PubMed ID: 32150447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.
    Moledina DG; Hall IE; Thiessen-Philbrook H; Reese PP; Weng FL; Schröppel B; Doshi MD; Wilson FP; Coca SG; Parikh CR
    Am J Kidney Dis; 2017 Dec; 70(6):807-816. PubMed ID: 28844586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423.
    Pavkovic M; Robinson-Cohen C; Chua AS; Nicoara O; Cárdenas-González M; Bijol V; Ramachandran K; Hampson L; Pirmohamed M; Antoine DJ; Frendl G; Himmelfarb J; Waikar SS; Vaidya VS
    Toxicol Sci; 2016 Jul; 152(1):205-13. PubMed ID: 27122240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kidney injury molecule-1 (Kim-1) gene reporter in a mouse artificial chromosome: the responsiveness to cisplatin toxicity in immortalized mouse kidney S3 cells.
    Kokura K; Kuromi Y; Endo T; Anzai N; Kazuki Y; Oshimura M; Ohbayashi T
    J Gene Med; 2016 Oct; 18(10):273-281. PubMed ID: 27591740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats.
    Vinken P; Starckx S; Barale-Thomas E; Looszova A; Sonee M; Goeminne N; Versmissen L; Buyens K; Lampo A
    Toxicol Pathol; 2012 Oct; 40(7):1049-62. PubMed ID: 22581811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Urine Platinum With Acute Kidney Injury in Children Treated With Cisplatin for Cancer.
    Lebel A; Chui H; McMahon KR; Lim YJ; Macri J; Wang S; Devarajan P; Blydt-Hansen TD; Zappitelli M; Urquhart BL
    J Clin Pharmacol; 2021 Jul; 61(7):871-880. PubMed ID: 33599997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.
    George B; Joy MS; Aleksunes LM
    Exp Biol Med (Maywood); 2018 Feb; 243(3):272-282. PubMed ID: 29231123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells.
    Sohn SJ; Kim SY; Kim HS; Chun YJ; Han SY; Kim SH; Moon A
    Toxicol Lett; 2013 Mar; 217(3):235-42. PubMed ID: 23287709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation.
    Wu WF; Wang JN; Li Z; Wei B; Jin J; Gao L; Li HD; Li J; Chen HY; Meng XM
    Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related differences in kidney injury biomarkers induced by cisplatin.
    Shin YJ; Kim TH; Won AJ; Jung JY; Kwack SJ; Kacew S; Chung KH; Lee BM; Kim HS
    Environ Toxicol Pharmacol; 2014 May; 37(3):1028-39. PubMed ID: 24751685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding.
    Soni H; Kaminski D; Gangaraju R; Adebiyi A
    Ren Fail; 2018 Nov; 40(1):314-322. PubMed ID: 29619879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
    Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer.
    Ravichandran K; Holditch S; Brown CN; Wang Q; Ozkok A; Weiser-Evans MC; Nemenoff R; Miyazaki M; Thiessen-Philbrook H; Parikh CR; Ljubanovic D; Edelstein CL
    Am J Physiol Renal Physiol; 2018 Mar; 314(3):F356-F366. PubMed ID: 29070568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of GSDMD contributes to acute kidney injury induced by cisplatin.
    Li Y; Xia W; Wu M; Yin J; Wang Q; Li S; Zhang A; Huang S; Zhang Y; Jia Z
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F96-F106. PubMed ID: 31682173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
    Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
    Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.